178 related articles for article (PubMed ID: 29413054)
1. A cross-sectional study examining the expression of splice variants K-RAS4A and K-RAS4B in advanced non-small-cell lung cancer patients.
Aran V; Masson Domingues P; Carvalho de Macedo F; Moreira de Sousa CA; Caldas Montella T; de Souza Accioly MT; Ferreira CG
Lung Cancer; 2018 Feb; 116():7-14. PubMed ID: 29413054
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of the K-ras gene in mouse tissues and cell lines.
Wang Y; You M; Wang Y
Exp Lung Res; 2001; 27(3):255-67. PubMed ID: 11293328
[TBL] [Abstract][Full Text] [Related]
3. K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif.
Tsai FD; Lopes MS; Zhou M; Court H; Ponce O; Fiordalisi JJ; Gierut JJ; Cox AD; Haigis KM; Philips MR
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):779-84. PubMed ID: 25561545
[TBL] [Abstract][Full Text] [Related]
4. K-Ras4A Plays a More Significant Role than K-Ras4B in Ductal Carcinoma of Breast.
Mortazavipour MM; Mohamadalizadeh-Hanjani Z; Geranpayeh L; Mahdian R; Shahbazi S
Iran Biomed J; 2023 Mar; 27(2 & 3):126-35. PubMed ID: 37070675
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Conformations of KRAS Isoforms, K-Ras4A and K-Ras4B, Points to Similarities and Significant Differences.
Chakrabarti M; Jang H; Nussinov R
J Phys Chem B; 2016 Feb; 120(4):667-79. PubMed ID: 26761128
[TBL] [Abstract][Full Text] [Related]
6. K-RAS4A: Lead or Supporting Role in Cancer Biology?
Aran V
Front Mol Biosci; 2021; 8():729830. PubMed ID: 34604308
[TBL] [Abstract][Full Text] [Related]
7. Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients.
Yang IS; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):40. PubMed ID: 29504894
[TBL] [Abstract][Full Text] [Related]
8. The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice.
Plowman SJ; Arends MJ; Brownstein DG; Luo F; Devenney PS; Rose L; Ritchie AM; Berry RL; Harrison DJ; Hooper ML; Patek CE
Exp Cell Res; 2006 Jan; 312(1):16-26. PubMed ID: 16271715
[TBL] [Abstract][Full Text] [Related]
9. Identification of Differentially Expressed K-Ras Transcript Variants in Patients With Leiomyoma.
Zolfaghari N; Shahbazi S; Torfeh M; Khorasani M; Hashemi M; Mahdian R
Reprod Sci; 2017 Oct; 24(10):1438-1443. PubMed ID: 28122482
[TBL] [Abstract][Full Text] [Related]
10. A New View of Ras Isoforms in Cancers.
Nussinov R; Tsai CJ; Chakrabarti M; Jang H
Cancer Res; 2016 Jan; 76(1):18-23. PubMed ID: 26659836
[TBL] [Abstract][Full Text] [Related]
11. PDEδ Binding to Ras Isoforms Provides a Route to Proper Membrane Localization.
Muratcioglu S; Jang H; Gursoy A; Keskin O; Nussinov R
J Phys Chem B; 2017 Jun; 121(24):5917-5927. PubMed ID: 28540724
[TBL] [Abstract][Full Text] [Related]
12. Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.
Jin H; Jang Y; Cheng N; Li Q; Cui PF; Zhou ZW; Jiang HL; Cho MH; Westover KD; Tan QY; Xu CX
J Exp Clin Cancer Res; 2019 Apr; 38(1):165. PubMed ID: 30987652
[TBL] [Abstract][Full Text] [Related]
13. K-Ras4B proteins are expressed in the nucleolus: Interaction with nucleolin.
Birchenall-Roberts MC; Fu T; Kim SG; Huang YK; Dambach M; Resau JH; Ruscetti FW
Biochem Biophys Res Commun; 2006 Sep; 348(2):540-9. PubMed ID: 16889753
[TBL] [Abstract][Full Text] [Related]
14. The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin.
Abraham SJ; Nolet RP; Calvert RJ; Anderson LM; Gaponenko V
Biochemistry; 2009 Aug; 48(32):7575-83. PubMed ID: 19583261
[TBL] [Abstract][Full Text] [Related]
15. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
[TBL] [Abstract][Full Text] [Related]
16. EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.
Créquit P; Ruppert AM; Rozensztajn N; Gounant V; Vieira T; Poulot V; Antoine M; Chouaid C; Wislez M; Cadranel J; Lavole A
Lung Cancer; 2016 Jun; 96():74-7. PubMed ID: 27133754
[TBL] [Abstract][Full Text] [Related]
17. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I.
Zhang FL; Kirschmeier P; Carr D; James L; Bond RW; Wang L; Patton R; Windsor WT; Syto R; Zhang R; Bishop WR
J Biol Chem; 1997 Apr; 272(15):10232-9. PubMed ID: 9092572
[TBL] [Abstract][Full Text] [Related]
19. [Detection of EGFR and K-ras mutations in non-small cell lung cancer using cytological specimens].
Lu SS; Xu X; Guo HQ; Cao J; Pan QJ; Wang MR
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):585-9. PubMed ID: 24314215
[TBL] [Abstract][Full Text] [Related]
20. Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.
Ulivi P; Romagnoli M; Chiadini E; Casoni GL; Capelli L; Gurioli C; Zoli W; Saragoni L; Dubini A; Tesei A; Amadori D; Poletti V
Int J Oncol; 2012 Jul; 41(1):147-52. PubMed ID: 22504767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
